GANXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Gain Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$1.25−0.01 (-0.79%)
Close on Oct 19, 2026
- Market cap
- $53.60M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
21.1%
9M of 44M shares
Institutional holders
50
12 new, 4 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of GANX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Marshall Wace, Llp | 1,923,546 | 4.41% | $3.90M | +153,758 | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 1,137,290 | 2.61% | $2.31K | +568,645 | 0.00% |
| Potomac Capital Management, Inc. | 946,400 | 2.17% | $1.92M | −62,200 | 1.31% |
| Gsa Capital Partners Llp | 632,131 | 1.45% | $1.28K | +319,664 | 0.08% |
| Jones Financial Companies Lllp | 608,592 | 1.39% | $1.07M | −23,023 | 0.00% |
| DME Capital Management, LP | 566,130 | 1.30% | $1.15M | – | 0.03% |
| Vanguard Capital Management LLC | 480,269 | 1.10% | $974.95K | +80,383 | 0.00% |
| Geode Capital Management, LLC | 453,501 | 1.04% | $921.37K | +6,159 | 0.00% |
| BlackRock, Inc. | 274,957 | 0.63% | $558.16K | +49,911 | 0.00% |
| Vanguard Fiduciary Trust Co | 231,534 | 0.53% | $470.01K | +1,555 | 0.00% |
| UBS Group AG | 215,012 | 0.49% | $436.48K | −5,477 | 0.00% |
| Stratos Wealth Partners, LTD. | 200,000 | 0.46% | $406.00K | +68,379 | 0.00% |
| Cresset Asset Management, LLC | 160,000 | 0.37% | $324.80K | – | 0.00% |
| State Street Corp | 157,537 | 0.36% | $319.80K | – | 0.00% |
| Citadel Advisors LLC | 154,524 | 0.35% | $313.68K | +129,624 | 0.00% |
| Squarepoint Ops LLC | 136,359 | 0.31% | $276.81K | New | 0.00% |
| Morgan Stanley | 125,972 | 0.29% | $255.72K | −13,680 | 0.00% |
| LPL Financial LLC | 117,251 | 0.27% | $238.02K | +13,000 | 0.00% |
| Northern Trust Corp | 97,013 | 0.22% | $196.94K | −16,984 | 0.00% |
| Susquehanna International Group, Llp | 78,206 | 0.18% | $158.76K | −353,061 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 50 | 9M | 21.1% | 12 / 15 | 9 / 4 | 2M | 1M |
| Q1 2026 | 42 | 8M | 18.8% | 10 / 9 | 10 / 15 | 2M | 1M |
| Q4 2025 | 48 | 8M | 18.5% | 21 / 15 | 3 / 10 | 5M | 1M |
| Q3 2025 | 38 | 4M | 10.0% | 9 / 14 | 4 / 6 | 1M | 0M |
| Q2 2025 | 35 | 4M | 8.7% | 6 / 11 | 5 / 4 | 1M | 0M |
| Q1 2025 | 33 | 3M | 6.4% | 10 / 12 | 2 / 2 | 1M | 0M |
| Q4 2024 | 25 | 2M | 4.5% | 10 / 8 | 2 / 4 | 1M | 0M |
| Q3 2024 | 19 | 2M | 3.8% | 3 / 5 | 4 / 11 | 1M | 2M |
| Q2 2024 | 28 | 3M | 7.0% | 8 / 9 | 7 / 6 | 2M | 1M |
| Q1 2024 | 26 | 2M | 4.3% | 6 / 11 | 6 / 3 | 1M | 0M |
| Q4 2023 | 24 | 2M | 3.5% | 3 / 8 | 6 / 3 | 0M | 0M |
| Q3 2023 | 24 | 2M | 3.5% | 2 / 9 | 6 / 2 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of GANX | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 430,902 | 0.99% | $874.73K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 207,106 | 0.47% | $403.86K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 144,159 | 0.33% | $292.64K | 0.02% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 57,335 | 0.13% | $111.80K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 55,636 | 0.13% | $108.49K | 0.00% | May 31, 2026 |
| Ultra-Small Company Market Fund | 30,004 | 0.07% | $60.91K | 0.04% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 28,629 | 0.07% | $55.83K | 0.00% | May 31, 2026 |
| 1290 VT Micro Cap Portfolio | 9,730 | 0.02% | $19.75K | 0.01% | Jun 30, 2026 |
| Total Stock Market Index Trust | 966 | 0.00% | $1.96K | 0.00% | Jun 30, 2026 |
| Blackstone Alternative Multi-Strategy Fund | -7,200 | -0.02% | -$14.62K | -0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Gene Mack | CEO, President, Director | 14,400 | 0.03% | Mar 26, 2026 |
| Gianluca Fuggetta | See Remark | – | – | Mar 26, 2026 |
| Khalid Islam | Director | 930,784 | 2.13% | Jul 17, 2026 |
| Dov A. Goldstein Md | Director | – | – | Jul 17, 2026 |
| Claude Nicaise | Director | – | – | Jul 17, 2026 |
| Jeffrey Scott Riley | Director | 30,000 | 0.07% | Jul 17, 2026 |
| Hans Peter Hasler | Director | – | – | Jul 17, 2026 |
| Gwen A. Melincoff | Director | – | – | Jul 17, 2026 |
| Eric I. Richman | Director | 304,458 | 0.70% | Jun 25, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Gene Mack CFO and Interim CEO | Aug 9, 2024 | Buy | +14,400 | $1.01 | $14.54K | 14,400 |
| Khalid Islam Executive Chairman, Director | Aug 9, 2024 | Buy | +50,000 | $1.00 | $50.00K | 50,000 |
| Eric I. Richman Director | Jul 1, 2024 | Buy | +12,000 | $1.21 | $14.52K | 289,629 |
| Eric I. Richman Director | Jul 1, 2024 | Buy | +5,000 | $1.23 | $6.15K | 277,629 |
| Jeffrey Scott Riley Director | Mar 28, 2024 | Buy | +30,000 | $3.86 | $115.80K | 30,000 |
| Matthias Alder Chief Executive Officer, Director | Mar 26, 2024 | Option exercise | +637 | – | – | 27,225 |
| Matthias Alder Chief Executive Officer, Director | Mar 26, 2024 | Option exercise | +18,750 | – | – | 25,763 |
| Matthias Alder Chief Executive Officer, Director | Mar 26, 2024 | Option exercise | +825 | – | – | 26,588 |
| Matthias Alder Chief Executive Officer, Director | Mar 26, 2024 | Tax withholding | −6,085 | $4.06 | $24.71K | 21,140 |
| Matthias Alder Chief Executive Officer, Director | Dec 21, 2023 | Sale | −206 | $2.46 | $507 | 5,286 |
| Matthias Alder Chief Executive Officer, Director | Dec 20, 2023 | Option exercise | +637 | – | – | 5,492 |
| Matthias Alder Chief Executive Officer, Director | Dec 7, 2023 | Sale | −1,820 | $2.50 | $4.55K | 4,855 |
| Matthias Alder Chief Executive Officer, Director | Oct 1, 2023 | Option exercise | +825 | – | – | 6,675 |
| Matthias Alder Chief Executive Officer, Director | Sep 20, 2023 | Option exercise | +2,550 | – | – | 5,850 |
| Eric I. Richman Director | Sep 20, 2023 | Option exercise | +54,900 | – | – | 272,629 |
| Matthias Alder Chief Executive Officer, Director | Jul 1, 2023 | Option exercise | +3,300 | – | – | 3,300 |
| Eric I. Richman CHIEF EXECUTIVE OFFICER, Director | May 25, 2022 | Buy | +2,482 | $2.58 | $6.40K | 217,729 |
| Eric I. Richman CHIEF EXECUTIVE OFFICER, Director | May 20, 2022 | Buy | +9,256 | $2.83 | $26.19K | 215,247 |
| Eric I. Richman CHIEF EXECUTIVE OFFICER, Director | May 19, 2022 | Buy | +4,000 | $2.71 | $10.84K | 205,991 |
| Salvatore Calabrese CHIEF FINANCIAL OFFICER | May 19, 2022 | Buy | +3,000 | $2.70 | $8.10K | 3,000 |
| Salvatore Calabrese CHIEF FINANCIAL OFFICER | May 19, 2022 | Buy | +3,000 | $8100.00 | $24.30M | – |
| Eric I. Richman Chief Executive Officer, Director | Aug 16, 2021 | Buy | +4,922 | $7.87 | $38.74K | 216,820 |
| Eric I. Richman Director | Aug 16, 2021 | Option exercise | +4,922 | $7.87 | $38.74K | 216,820 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.